Press releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Jul 29, 2009
Election of Bartlett and Byrnes increases the Boston Scientific Board to 13 members
-
Jul 20, 2009
"We delivered sales and earnings at the high end of our guidance range,” Ray Elliott, President and CEO
-
Jul 16, 2009
Longest available drug-eluting stent strengthens Company's broad portfolio
-
Jul 13, 2009
System remotely monitors patients with implantable cardiac devices, gathering information on both the device and a patient's heart health status
-
Jul 7, 2009
Learn how to tune in or find the replay of the July 21 conference call
-
Jun 25, 2009
“We are confident Ray offers the right combination of experience, results and talents for Boston Scientific going forward,” said board chairman Pete Nicholas
-
Jun 23, 2009
Landmark trial shows Boston Scientific CRT-Ds slow the progression of heart failure in asymptomatic and mildly symptomatic patients NATICK, Mass., June 23 /PRNewswire-FirstCall/ -- Boston...
-
Jun 18, 2009
A live webcast and replay of the June 24th conference session will be available.
-
Jun 15, 2009
Presentations to feature results on pelvic floor reconstruction systems and mid-urethral sling systems
-
May 28, 2009
Studies to be presented on safety and efficacy of SpyGlass System for diagnostic and therapeutic procedures throughout pancreatico-biliary system NATICK, Mass., May 28 /PRNewswire-FirstCall/ --...
-
May 28, 2009
SpyGlass® Direct Visualization System can now be used for diagnostic and therapeutic procedures for pancreatic disease NATICK, Mass., May 28 /PRNewswire-FirstCall/ -- Boston Scientific...
-
May 27, 2009
"We are grateful for their service to Boston Scientific and its customers, patients and shareholders," said Pete Nicholas, Chairman of the Board
-
May 27, 2009
Specifically designed for treating small coronary vessels; joins the TAXUS® Express® Atom™ Stent as the only drug-eluting stents approved for small vessel use in the U.S.
-
May 26, 2009
Risk of death at five years is lower for aneurysm patients treated with coil embolization compared to surgical clipping
-
May 20, 2009
ORION clinical trial to evaluate the Company's EPIC™ Self-Expanding Nitinol Stent System for the treatment of iliac artery disease
-
May 20, 2009
Boston Scientific Corporation (NYSE: BSX) today announced results from an analysis of economic and quality of life outcomes,...
-
May 19, 2009
Boston Scientific Corporation (NYSE: BSX) today announced that Fitch Ratings has raised the Company's rating outlook to positive from stable, while...
-
May 19, 2009
Results support previously announced outcomes with PCI and CABG in patients with left main coronary disease
-
May 19, 2009
TAXUS® Element™ Drug-Eluting Stent is now available in select markets worldwide
-
May 19, 2009
Online tools will help physicians determine treatment strategies
-
May 15, 2009
A live webcast and replay of the May 22 conference will be available.
-
May 15, 2009
Presentations to include additional analyses from the landmark SYNTAX trial
-
May 14, 2009
ALTITUDE analysis presented at the Heart Rhythm Society Scientific Sessions
-
May 14, 2009
Analysis indicates that one life is now saved for every six patients who receive an ICD
-
May 13, 2009
Donation marks the beginning of Company's agreement to provide the non-profit organization with CRM devices that would otherwise remain unused